ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

0A9B Synlab Ag

0.00
0.00 (0.00%)
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synlab Ag LSE:0A9B London Ordinary Share DE000A2TSL71 SYNLAB ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6 -
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Spec Outpatient Facility,nec 3.28B 150.7M 0.6859 15.91 2.4B

Goldman Sachs Bank Europe SE Synlab AG -- Mid-Stabilisation Notice (8085X)

06/05/2021 11:53am

UK Regulatory


Synlab (LSE:0A9B)
Historical Stock Chart


From Mar 2021 to Mar 2024

Click Here for more Synlab Charts.

TIDM0A9B

RNS Number : 8085X

Goldman Sachs Bank Europe SE

06 May 2021

Not for distribution, directly or indirectly, in or into the United States, Australia, Canada or Japan.

Synlab AG

Mid-stabilisation Notice in accordance with Articles 6(2) and 8 of Commission Delegated Regulation (EU) 2016/1052

06 May 2021

Goldman Sachs Bank Europe SE (contact: Philipp Suess; telephone: +49 69 7532 1267) hereby gives notice that the entity undertaking stabilisation (the "Stabilisation Manager" named below and its affiliates) undertook stabilisation of the offer of the following securities in accordance with Article 5(4) and (5) of Regulation (EU) No 596/2014 (Market Abuse Regulation) and Articles 5 through 8 of Commission Delegated Regulation (EU) 2016/1052.

 
 The securities: 
 Issuer:                    Synlab AG 
                           ---------------------------------------------- 
 Securities:                Ordinary bearer shares of the Issuer (ISIN: 
                             DE000A2TSL71) 
                           ---------------------------------------------- 
 Base Shares:               37,292,222 ordinary bearer shares 
                           ---------------------------------------------- 
 Stabilisation: 
 Stabilisation Manager      Goldman Sachs Bank Europe SE, Marienturm, 
  (and central point         Taunusanlage 9-10, D-60329 Frankfurt am Main 
  within the meaning 
  of Commission Delegated 
  Regulation (EU) 
  2016/1052): 
                           ---------------------------------------------- 
 

For each of the dates during which stabilisation transactions were carried out during the period covered by this notice (i.e., 30 April 2021 to 05 May 2021), the aggregate quantity and price range was as follows:

 
 Execution      Buy /    Aggregate   Lowest     Highest    Currency   Stabilisation 
  Date           Sell     Quantity    Price      Price                 Trading Venue 
 30-Apr-2021    Buy      1,002,836   EUR17.98   EUR18.00   EUR        XETR 
               -------  ----------  ---------  ---------  ---------  --------------- 
 

Disclaimer and Other Notices

This announcement is for information only and does not constitute an offer or invitation to underwrite, subscribe for or otherwise acquire or dispose of any securities or investment advice in any jurisdiction in which such an offer or solicitation is unlawful, including without limitation, the United States, Australia, Canada, or Japan. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

This announcement and the information contained herein is not an offer of securities for sale in, and is not for transmission to or publication, distribution or release, directly or indirectly, in the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"). The securities being offered have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), or under any applicable securities laws of any state or other jurisdiction of the United States and may not be offered, sold, resold, transferred or delivered, directly or indirectly, in the United States unless registered under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, such registration requirements and in accordance with any applicable securities laws of any state or other jurisdiction of the United States. No public offering of the securities discussed herein is being made in the United States.

Solely for the purpose of the product governance requirements contained within; (a) EU Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the shares have been subject to a product approval process, which has determined that the shares are; (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, the price of the shares may decline and investors could lose all or part of their investment; the shares offer no guaranteed income and no capital protection; and an investment in the shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Offering.

For the avoidance of doubt, the Target Market Assessment does not constitute; (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the shares. Each distributor is responsible for undertaking its own target market assessment in respect of the shares and determining appropriate distribution channels.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

STABGGDUGUGDGBL

(END) Dow Jones Newswires

May 06, 2021 06:53 ET (10:53 GMT)

1 Year Synlab Chart

1 Year Synlab Chart

1 Month Synlab Chart

1 Month Synlab Chart

Your Recent History

Delayed Upgrade Clock